| | Family Health | Baby Health
RSV in Babies: Symptoms, Treatment & Prevention Guide
Respiratory Syncytial Virus (RSV) is the leading cause of bronchiolitis and pneumonia in infants under 1 year. Nearly all children contract it by age 2. Most cases are mild; high-risk infants can develop severe disease.
Transmission
- Respiratory droplets (cough/sneeze), direct contact, contaminated surfaces (viable hours).
- Incubation: 2–8 days. Contagious 3–8 days (weeks in immunocompromised).
- Seasonal: Fall–spring peaks (varies by region).
Symptoms (Typically Appear in Stages)
- Upper Respiratory: Runny nose, congestion, mild cough, low-grade fever, decreased appetite.
- Lower Respiratory (Bronchiolitis): Wheezing, rapid/shallow breathing, nasal flaring, grunting, retractions (chest sinking in), cyanosis (blue lips/nails), lethargy, dehydration (fewer wet diapers).
- Apnea: Pauses in breathing — especially in young infants/preemies.
When to Seek Immediate Care
- Difficulty breathing (retractions, nasal flaring, grunting, >60 breaths/min)
- Bluish lips/face
- Inability to feed / signs of dehydration (no tears, dry mouth, <3 wet diapers/24h)
- Fever >100.4°F (38°C) in infant <3 months
- Extreme lethargy / difficult to arouse
- Apnea episodes
High-Risk Infants (Need Lower Threshold for Care)
- Premature (<35 weeks gestation)
- <6 months chronological age
- Chronic lung disease (BPD)
- Congenital heart disease (hemodynamically significant)
- Neuromuscular disorders, immunodeficiency
Treatment (Supportive — No Routine Antiviral)
- Hydration: Frequent small feeds. IV fluids if unable to maintain orally.
- Nasal Suctioning: Saline drops + bulb syringe/aspirator before feeds/sleep.
- Fever/Pain: Acetaminophen (≥2 mos) or ibuprofen (≥6 mos) per weight dosing.
- Oxygen: For hypoxia (SpO₂ <90–92%).
- Hospitalization Indications: Respiratory distress, hypoxia, apnea, dehydration, high-risk infant.
- NOT Routinely Used: Albuterol (no consistent benefit), steroids, antibiotics (unless bacterial co-infection), chest physiotherapy.
Prevention
For All Infants
- Hand hygiene (soap/water 20 sec or sanitizer).
- Limit exposure to sick people; avoid crowds in peak season.
- No smoking/vaping exposure.
- Breastfeeding (antibodies in milk).
- Surface disinfection.
For High-Risk Infants: Palivizumab (Synagis)
- Monoclonal antibody. Monthly IM injections during RSV season (typically 5 doses).
- Indications: <29 wks GA; <32 wks GA + CLD; hemodynamically significant CHD; others per AAP guidelines.
- Reduces hospitalization ~50%. Does not prevent infection.
New: Maternal RSV Vaccine (Abrysvo)
- Given 32–36 weeks gestation (Sept–Jan in US). Transfers antibodies to fetus.
- Reduces severe RSV in infants <6 months by ~80%.
New: Nirsevimab (Beyfortus)
- Long-acting monoclonal antibody. Single dose at birth or start of season.
- For all infants <8 months entering first RSV season; high-risk 8–19 months entering second season.
- >75% efficacy against medically attended RSV.
RSV is common and usually mild. Vigilance for breathing difficulty and dehydration—especially in high-risk babies—ensures timely intervention.
Baby Health - Related Articles
- Flunitrazepam (Rohypnol) & Pregnancy: Risks to the Developing Baby
- Infant Formula Regulations: Ensuring Safety and Nutrition | FDA
- Starting Solids: Stage 1 Foods, Readiness Signs & Progression Guide
- Infant Fontanelles: Anatomy, Closure Timelines & Clinical Assessment Guide
- Radiation Safety in Breast Milk: What Parents Need to Know
- Infant Colic: Causes, Relief & What Works
- Baby's Blood Type: Possible Combinations When Mom Is O and Dad Is AB+
